MediGroup EBI has introduced breakthrough medical technologies to Australia and New Zealand since 2004. We are recognised for advancing standards of care across high-impact specialties, including cardiothoracic and neurosurgery, by partnering with leading global innovators to equip clinicians managing complex and critical cases.

 

Our focus lies in identifying and distributing niche, high-performance medical technologies that give clinicians the tools, techniques and confidence to achieve better patient outcomes. With a strong track record in securing regulatory approval and reimbursement, we specialise in bringing new products — and often entirely new product categories — into the market.

 

We work closely with government bodies, regulators, hospitals and clinicians, doing what it takes to make world-class medical devices accessible to patients. Acting as both regulatory sponsor and distributor, we build long-term partnerships with our suppliers under robust commercial and compliance frameworks.

We are now extending this expertise into Intensive Care, applying the same emphasis on precision, performance and measurable clinical outcomes. Our evolving portfolio is centred on transformative technologies that support ICU teams when patients are at their most vulnerable.

 

MediGroup EBI represents trusted partnerships, bold innovation and a commitment to elevating standards of care across the most demanding areas of modern medicine.